LAST PRICE - AT THE CLOSE
DRUG is DOWN -2% since the begininning of the year
DRUG is UP 1% ABOVE 20 day SMA
DRUG is DOWN 0% BELOW 200 day SMA
PROFITABLE: NO
EPS: $-0.793275
EARNINGS MOMENTUM: YES
0.38% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
 |
THE STOCK IS 38.2% AWAY FROM ALL-TIME HIGHS OF $123.75 |
 |
DRUG IS DOWN -2% SINCE THE BEGINNING OF THE YEAR |
 |
DRUG IS UP 80% OVER THE PAST 12 MONTHS |
 |
DRUG IS UP 3% OVER THE PAST 1 MONTH |
 |
13% OF ALL DRUG INVESTORS ARE BETTING AGAINST DRUG |
 |
NUM INVESTORS SHORT DRUG HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|
 |
DRUG moved up 0 in the previous minute |
 |
DRUG is up 1.97 over the last hour |
 |
DRUG is up 5.4% over the last 5 days |
 |
DRUG is 3.8 above its 8 day SMA |
| $75.28 |   DAY |
$77.98 |
| $77.00 | PREVIOUS DAY |
$80.25 |
| $77.00 | WEEK |
$83.00 |
| $68.80 |  MONTH |
$83.00 |
| $38.00 | YEAR |
$123.75 |
DRUG is mentioned N/A less than normal on 
DRUG is mentioned N/A times in an average day on 
